EMAIL THIS PAGE TO A FRIEND

European heart journal

Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis.


PMID 25898844

Abstract

Osteopontin (OPN) is a multifunctional cytokine critically involved in cardiac fibrosis. However, the underlying mechanisms are unresolved. Non-coding RNAs are powerful regulators of gene expression and thus might mediate this process. OPN and miR-21 were significantly increased in cardiac biopsies of patients with myocardial fibrosis. Ang II infusion via osmotic minipumps led to specific miRNA regulations with miR-21 being strongly induced in wild-type (WT) but not OPN knockout (KO) mice. This was associated with enhanced cardiac collagen content, myofibroblast activation, ERK-MAP kinase as well as AKT signalling pathway activation and a reduced expression of Phosphatase and Tensin Homologue (PTEN) as well as SMAD7 in WT but not OPN KO mice. In contrast, cardiotropic AAV9-mediated overexpression of OPN in vivo further enhanced cardiac fibrosis. In vitro, Ang II induced expression of miR-21 in WT cardiac fibroblasts, while miR-21 levels were unchanged in OPN KO fibroblasts. As pri-miR-21 was also increased by Ang II, we studied potential involved upstream regulators; Electrophoretic Mobility Shift and Chromatin Immunoprecipitation analyses confirmed activation of the miR-21 upstream-transcription factor AP-1 by Ang II. Recombinant OPN directly activated miR-21, enhanced fibrosis, and activated the phosphoinositide 3-kinase pathway. Locked nucleic acid-mediated miR-21 silencing ameliorated cardiac fibrosis development in vivo. In cardiac fibrosis related to Ang II, miR-21 is transcriptionally activated and targets PTEN/SMAD7 resulting in increased fibroblast survival. OPN KO animals are protected from miR-21 increase and fibrosis development due to impaired AP-1 activation and fibroblast activation.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

O7635 Anti-Osteopontin antibody produced in goat, affinity isolated antibody, lyophilized powder
O3389 Anti-Osteopontin antibody produced in goat, affinity isolated antibody, lyophilized powder
O7264 Anti-Osteopontin antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4502841
Anti-Osteopontin, C-Terminal antibody produced in rabbit, affinity isolated antibody
AV36677
Anti-SPP1 antibody produced in rabbit, IgG fraction of antiserum
HPA027541
Anti-SPP1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab2
SAB2104323
Anti-SPP1, (N-terminal) antibody produced in rabbit, affinity isolated antibody
51800C Claycomb Medium, without L-glutamine, liquid, sterile-filtered, suitable for cell culture
S4250
D-Serine, ≥98% (TLC)
C3H7NO3
12103C
Fetal Bovine Serum, USA origin, cell culture tested
G7513
L-Glutamine solution, 200 mM, solution, sterile-filtered, BioXtra, suitable for cell culture
SAB4200018
Monoclonal Anti-Osteopontin antibody produced in mouse, ~1.0 mg/mL, clone OPN46, purified immunoglobulin, buffered aqueous solution
WH0006696M1
Monoclonal Anti-SPP1 antibody produced in mouse, clone 1E10, purified immunoglobulin, buffered aqueous solution
SAB1404404
Monoclonal Anti-SPP1 antibody produced in mouse, clone 4H7, purified immunoglobulin, buffered aqueous solution
O2260 Osteopontin from mouse, >95% (SDS-PAGE), recombinant, expressed in NSO cells, lyophilized powder, cell culture tested
O4264 Osteopontin human, recombinant, expressed in NSO cells, ≥95% (SDS-PAGE), lyophilized powder, cell culture tested
SRP3131 Osteopontin human, recombinant, expressed in HEK 293 cells, ≥97% (SDS-PAGE), ≥97% (HPLC), cell culture tested
P4333
Penicillin-Streptomycin, Solution stabilized, with 10,000 units penicillin and 10 mg streptomycin/mL, sterile-filtered, BioReagent, suitable for cell culture
W1628
Wortmannin, from Penicillium funiculosum, ≥98% (HPLC and TLC)
C23H24O8